Skip to content

Drug interactions

Avanafil + Zafirlukast

Severity: Minor

Avanafil and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Avanafil is a sensitive CYP3A4 substrate, and inhibitors of this enzyme can increase its exposure and the risk of hypotension, headache and flushing. Zafirlukast is only a weak CYP3A4 inhibitor, so the effect is likely modest.

What this interaction means in plain words

Avanafil and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Avanafil belongs to Genitourinary; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Zafirlukast weakly inhibits CYP3A4, reducing avanafil clearance.

What to do

Start with the usual avanafil dose and monitor for hypotension and other adverse effects. Reassess if symptoms develop.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avanafil and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Avanafil with Zafirlukast?

MediHelp rates the interaction as minor. Avanafil and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Avanafil is a sensitive CYP3A4 substrate, and inhibitors of this enzyme can increase its exposure and the risk of hypotension, headache and flushing. Zafirlukast is only a weak CYP3A4 inhibitor, so the effect is likely modest.

How serious is the interaction between Avanafil and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Start with the usual avanafil dose and monitor for hypotension and other adverse effects. Reassess if symptoms develop.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in